Randen Patterson

Title: Innovations and Contributions of Inventor Randen Patterson

Introduction

Randen Patterson is a notable inventor based in University Park, PA (US). He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic approaches.

Latest Patents

Randen Patterson holds two patents that showcase his inventive prowess. His latest patents include a synthetic peptide modeled on the IRCX binding area of NHE3, which acts as a competitive inhibitor of the IRCX. This invention not only stimulates basal NHE3 activity but also prevents elevated Ca and cAMP inhibition of NHE3. The methods of its preparation and use are aimed at preventing and treating gastrointestinal diseases, such as diarrhea. Another patent focuses on the regulation of cell survival by HSP90 and IP6K2. This invention identifies anti-cancer drugs by screening for agents and compounds that inhibit the binding of HSP90 and IP6K2. Various in vitro and in vivo assays can be utilized to monitor phenomena associated with this binding or inhibition, including cell death and catalytic activity of IP6K2.

Career Highlights

Throughout his career, Randen Patterson has worked with prestigious institutions, including The Johns Hopkins University and the Penn State Research Foundation. His work has significantly advanced the understanding of gastrointestinal diseases and cancer treatment.

Collaborations

Randen has collaborated with notable colleagues, including Damian Brett Van Rossum and Mark Donowitz. These collaborations have further enriched his research and contributions to the field.

Conclusion

Randen Patterson's innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the fields of gastrointestinal health and cancer research.